Skip to main content
. 2018 Oct 18;2018(10):CD009431. doi: 10.1002/14651858.CD009431.pub3

Yeoh 1997.

Methods Randomised, double‐blind,placebo‐controlled trial. Single‐centre, Criteria for FD: equivalent symptom and included both types of FD
Participants N = 104
Female: 53%
Mean age:43.5+/‐2.2 years for the gastritis group and 35.6+/‐1.5 years for the non‐gastritis group
Country: Singapore
Interventions Intervention: cisapride 10 mg orally three times a day
Comparator: placebo
Rescue medication: antacid (open‐labelled)
Duration of treatment: 4 weeks
Outcomes Symptoms of epigastric pain, bloating, nausea, belching, early satiety and heartburn were graded on a 4‐point scale were assessed by participants
A global response by physicians‐(i) poor, no change or deterioration of symptoms; (ii) fair, clear but limited improvement; (iii) good, considerable overall improvement; and (iv) excellent, complete or almost complete disappearance of symptoms
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "Randomly allocated"
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Double‐blinded
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Scores were assessed by participants, global response was assessed by physicians. It is not clear if outcome assessors were blinded
Incomplete outcome data (attrition bias) 
 All outcomes High risk 27% (28/104) participants did not complete the study
Selective reporting (reporting bias) Low risk Reproted all pre‐defined outcomes
Other bias Low risk No other risk of bias found